Literature DB >> 29452756

Quantification of thrombus formation in malapposed coronary stents deployed in vitro through imaging analysis.

Jonathan Brown1, Caroline C O'Brien2, Augusto C Lopes2, Kumaran Kolandaivelu3, Elazer R Edelman3.   

Abstract

Stent thrombosis is a major complication of coronary stent and scaffold intervention. While often unanticipated and lethal, its incidence is low making mechanistic examination difficult through clinical investigation alone. Thus, throughout the technological advancement of these devices, experimental models have been indispensable in furthering our understanding of device safety and efficacy. As we refine model systems to gain deeper insight into adverse events, it is equally important that we continue to refine our measurement methods. We used digital signal processing in an established flow loop model to investigate local flow effects due to geometric stent features and ultimately its relationship to thrombus formation. A new metric of clot distribution on each microCT slice termed normalized clot ratio was defined to quantify this distribution. Three under expanded coronary bare-metal stents were run in a flow loop model to induce clotting. Samples were then scanned in a MicroCT machine and digital signal processing methods applied to analyze geometric stent conformation and spatial clot formation. Results indicated that geometric stent features play a significant role in clotting patterns, specifically at a frequency of 0.6225 Hz corresponding to a geometric distance of 1.606 mm. The magnitude-squared coherence between geometric features and clot distribution was greater than 0.4 in all samples. In stents with poor wall apposition, ranging from 0.27 mm to 0.64 mm maximum malapposition (model of real-world heterogeneity), clots were found to have formed in between stent struts rather than directly adjacent to struts. This early work shows how the combination of tools in the areas of image processing and signal analysis can advance the resolution at which we are able to define thrombotic mechanisms in in vitro models, and ultimately, gain further insight into clinical performance.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Image analysis; Malaposition; MicroCT; Stent; Thrombosis

Mesh:

Year:  2018        PMID: 29452756      PMCID: PMC5878124          DOI: 10.1016/j.jbiomech.2018.01.044

Source DB:  PubMed          Journal:  J Biomech        ISSN: 0021-9290            Impact factor:   2.712


  18 in total

1.  Low background, pulsatile, in vitro flow circuit for modeling coronary implant thrombosis.

Authors:  Kumaran Kolandaivelu; Elazer R Edelman
Journal:  J Biomech Eng       Date:  2002-12       Impact factor: 2.097

2.  Optimization of cardiovascular stent design using computational fluid dynamics.

Authors:  Timothy J Gundert; Alison L Marsden; Weiguang Yang; John F LaDisa
Journal:  J Biomech Eng       Date:  2012-01       Impact factor: 2.097

Review 3.  Role of stent design and coatings on restenosis and thrombosis.

Authors:  Hidehiko Hara; Masato Nakamura; Julio C Palmaz; Robert S Schwartz
Journal:  Adv Drug Deliv Rev       Date:  2006-03-06       Impact factor: 15.470

4.  Bioresorbable Scaffolds versus Metallic Stents in Routine PCI.

Authors:  Joanna J Wykrzykowska; Robin P Kraak; Sjoerd H Hofma; Rene J van der Schaaf; E Karin Arkenbout; Alexander J IJsselmuiden; Joëlle Elias; Ivo M van Dongen; Ruben Y G Tijssen; Karel T Koch; Jan Baan; M Marije Vis; Robbert J de Winter; Jan J Piek; Jan G P Tijssen; Jose P S Henriques
Journal:  N Engl J Med       Date:  2017-03-29       Impact factor: 91.245

5.  Possible Subclinical Leaflet Thrombosis in Bioprosthetic Aortic Valves.

Authors:  Raj R Makkar; Gregory Fontana; Hasan Jilaihawi; Tarun Chakravarty; Klaus F Kofoed; Ole De Backer; Federico M Asch; Carlos E Ruiz; Niels T Olsen; Alfredo Trento; John Friedman; Daniel Berman; Wen Cheng; Mohammad Kashif; Vladimir Jelnin; Chad A Kliger; Hongfei Guo; Augusto D Pichard; Neil J Weissman; Samir Kapadia; Eric Manasse; Deepak L Bhatt; Martin B Leon; Lars Søndergaard
Journal:  N Engl J Med       Date:  2015-10-05       Impact factor: 91.245

6.  Endovascular stent design dictates experimental restenosis and thrombosis.

Authors:  C Rogers; E R Edelman
Journal:  Circulation       Date:  1995-06-15       Impact factor: 29.690

7.  Early stent thrombosis in patients with acute coronary syndromes treated with drug-eluting and bare metal stents: the Acute Catheterization and Urgent Intervention Triage Strategy trial.

Authors:  Jiro Aoki; Alexandra J Lansky; Roxana Mehran; Jeffery Moses; Michel E Bertrand; Brent T McLaurin; David A Cox; A Michael Lincoff; E Magnus Ohman; Harvey D White; Helen Parise; Martin B Leon; Gregg W Stone
Journal:  Circulation       Date:  2009-01-26       Impact factor: 29.690

8.  Vascular Response to Experimental Stent Malapposition and Under-Expansion.

Authors:  Caroline C O'Brien; Augusto C Lopes; Kumaran Kolandaivelu; Mie Kunio; Jonathan Brown; Vijaya B Kolachalama; Claire Conway; Lynn Bailey; Peter Markham; Marco Costa; James Ware; Elazer R Edelman
Journal:  Ann Biomed Eng       Date:  2016-01-05       Impact factor: 3.934

9.  Constraining OCT with Knowledge of Device Design Enables High Accuracy Hemodynamic Assessment of Endovascular Implants.

Authors:  Caroline C O'Brien; Kumaran Kolandaivelu; Jonathan Brown; Augusto C Lopes; Mie Kunio; Vijaya B Kolachalama; Elazer R Edelman
Journal:  PLoS One       Date:  2016-02-23       Impact factor: 3.240

10.  Incomplete stent apposition causes high shear flow disturbances and delay in neointimal coverage as a function of strut to wall detachment distance: implications for the management of incomplete stent apposition.

Authors:  Nicolas Foin; Juan Luis Gutiérrez-Chico; Shimpei Nakatani; Ryo Torii; Christos V Bourantas; Sayan Sen; Sukhjinder Nijjer; Ricardo Petraco; Chrysa Kousera; Matteo Ghione; Yoshinobu Onuma; Hector M Garcia-Garcia; Darrel P Francis; Philip Wong; Carlo Di Mario; Justin E Davies; Patrick W Serruys
Journal:  Circ Cardiovasc Interv       Date:  2014-03-18       Impact factor: 6.546

View more
  3 in total

Review 1.  An Overview of In Vitro Drug Release Methods for Drug-Eluting Stents.

Authors:  Navideh Abbasnezhad; Nader Zirak; Stéphane Champmartin; Mohammadali Shirinbayan; Farid Bakir
Journal:  Polymers (Basel)       Date:  2022-07-05       Impact factor: 4.967

2.  Long-term (beyond 5 years) clinical impact of Xience everolimus-eluting stent implantation.

Authors:  Hiroaki Matsuda; Yoriyasu Suzuki
Journal:  Health Sci Rep       Date:  2021-09-08

3.  Midterm Clinical Impacts of Biodegradable Polymer Everolimus-Eluting Stents Compared with Durable Polymer Everolimus-Eluting Stents: A 3-Year Propensity-Matched Study.

Authors:  Hiroaki Matsuda; Ai Kagase; Takahiro Tokuda; Yusuke Ochiumi; Akira Murata; Yoriyasu Suzuki; Tatsuya Ito
Journal:  J Interv Cardiol       Date:  2020-04-20       Impact factor: 2.279

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.